Company / Capital Expenditures
Lantheus Holdings Capital Expenditures History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$45.3M
FY2023
5-year range
$0 / $260.0M
FY2019-FY2023
Trend
-82.6%
vs FY2022
Sector context
#81 of 151
Health Care
What the data says
At $45M, Lantheus Holdings's capital expenditures ranks #81 of 151 in the Health Care sector. Capital Expenditures has fluctuated over the past 8 years, ranging from $0 in FY2021 to $260M in FY2022.
Based on SEC 10-K filings.
$45M in FY2023 with a 5-year CAGR of +43.7%.
Improved from $0 to $45M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +43.7%
- 10-Year CAGR
- -
Sector benchmark
#81 of 151 in Health CareTop 54% of 151This company $45.3M Sector average $271.7M
▼
-83.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +43.7%, indicating consistent growth.
- In FY2023, capital expenditures decreased 82.6% year-over-year.
- Ranks #81 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $45.3M | -82.6% |
| FY2022 | $260.0M | - |
| FY2021 | $0 | - |
| FY2020 | $0 | -100.0% |
| FY2019 | $22.1M | +198.2% |
| FY2018 | $7.4M | -43.7% |
| FY2017 | $13.2M | +61.6% |
| FY2016 | $8.1M | +62.4% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026